Fukuoka University Hospital
In research, Fukuoka University Hospital stands highest in Medicine (#8,070 of 10,443 worldwide) and Health Sciences (#9,855 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine and Surgery — Pulmonary and Respiratory Medicine is 9.0× its share of world research.
- World rank, 2022–2025
- #16,994 of 28,054 · #28,340 all time
- Rank in Japan
- #457 of 1,070
- Research works
- 810 ▲ 16% vs 2013–17
- Citations
- 7.6k 9.3 per fractional work
- Top-10% rate
- 5.7% record average 16.5%
- Open access
- 55% world 28%
What is Fukuoka University Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,070 of 10,443 | 4.8% | 140 | #11615 | |
| Health SciencesDomain | #9,855 of 11,982 | 4.9% | 144 | #14577 |
Each strip is that field’s whole ranked pool, with the notch where Fukuoka University Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Fukuoka University Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 9.0× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 23.3 works9.0×
- SurgerySubfield · 24.9 works6.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
- Medicine 4.3×
- Pharmacology, Toxicology and Pharmaceutics 3.8×
- Immunology and Microbiology 3.1×
- Veterinary 2.9×
- Dentistry 1.2×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Health Professions 0.5×
- Neuroscience 0.3×
- Nursing 0.2×
- Physics and Astronomy 0.2×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
- Chemistry 0.1×
- Computer Science 0.0×
- Materials Science 0.0×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
- Business, Management and Accounting 0.0×
- Environmental Science 0.0×
Who are the top researchers at Fukuoka University Hospital?
Ranked on the composite score, Yasushi Takamatsu, Hideko Nakashima and Makoto Hamasaki lead among researchers whose main affiliation is Fukuoka University Hospital.
- 1 Yasushi Takamatsu Japan · #131,059 worldwide 115 citations · 52 works
- 2 Hideko Nakashima Japan · #781,761 worldwide 33 citations · 16 works
- 3 Makoto Hamasaki Japan · #936,620 worldwide 47 citations · 25 works
- 4 Naoki Hamada Japan · #1,027,153 worldwide 28 citations · 34 works
- 5 Hideichi Wada Japan · #1,126,232 worldwide 1 citations · 17 works
- 6 Kentaro Ogata Japan · #1,360,450 worldwide 6 citations · 30 works
- 7 Masaki Fujita Japan · #1,487,119 worldwide 23 citations · 26 works
Which keywords describe research at Fukuoka University Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Diagnosis, Treatment, Immunotherapy, Inflammation, Clinical Practice Guidelines and Prognostic Factors.
- Clinical Management
- Immune Checkpoint Blockade
- Percutaneous Coronary Intervention
- SARS-CoV-2
- Echocardiography
- Treatment Guidelines
- Neoadjuvant Therapy
- Fibrosis
- Guidelines
- Antibiotic Resistance
- Thrombosis
- Genetic Mutations
- Risk Factors
- Clinical Trials
- Cardiovascular Disease
- Prognostic Factors
- Immune Response
- Immunotherapy
- Diagnosis
- Inflammation
- Epidemiology
- Chemotherapy
- Treatment
- Clinical Practice Guidelines
- Management
- Quality of Life
- Tumor Microenvironment
- Heart Failure
- Surgical Management
- Targeted Therapy
- Complications
- Radiotherapy
- Tumor Markers
- Metastasis
- TGF-ß
- Crohn's Disease
- Adjuvant Therapy
- Interstitial Lung Disease
- Endovascular Treatment
- PD-1 and PD-L1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology26▲ 3.8×70 topics
- Inflammation12▲ 3.3×47 topics
- Chemotherapy11▲ 9.4×16 topics
- Diagnosis11▲ 7.0×27 topics
- Treatment10▲ 5.1×25 topics
- Immunotherapy8▲ 6.8×16 topics
- Clinical Practice Guidelines7▲ 7.8×14 topics
- Immune Response7▲ 6.9×13 topics
- Management7▲ 5.0×22 topics
- Prognostic Factors6▲ 8.8×12 topics
- Quality of Life6▲ 2.4×23 topics
- Cardiovascular Disease6▲ 3.0×21 topics
- Tumor Microenvironment5▲ 7.1×7 topics
- Clinical Trials5▲ 4.6×6 topics
- Heart Failure5▲ 7.0×10 topics
- Risk Factors5▲ 2.8×17 topics
- Surgical Management5▲ 6.9×14 topics
- Genetic Mutations5▲ 6.5×15 topics
- Targeted Therapy5▲ 12×3 topics
- Thrombosis4▲ 9.0×6 topics
- Complications4▲ 4.9×13 topics
- Antibiotic Resistance4▲ 6.1×8 topics
- Radiotherapy4▲ 6.0×10 topics
- Guidelines4▲ 4.8×10 topics
- Tumor Markers4▲ 28×2 topics
- Fibrosis4▲ 12×6 topics
- Metastasis4▲ 6.3×6 topics
- Neoadjuvant Therapy4▲ 9.2×5 topics
- TGF-ß4▲ 14×3 topics
- Treatment Guidelines3▲ 9.1×5 topics
- Crohn's Disease3▲ 24×2 topics
- Echocardiography3▲ 6.9×7 topics
- Adjuvant Therapy3▲ 14×2 topics
- SARS-CoV-23▲ 5.7×4 topics
- Interstitial Lung Disease3▲ 27×2 topics
- Percutaneous Coronary Intervention3▲ 13×4 topics
- Endovascular Treatment3▲ 29×2 topics
- Immune Checkpoint Blockade3▲ 15×1 topic
- PD-1 and PD-L13▲ 15×1 topic
- Clinical Management3▲ 9.1×5 topics
Which research topics does Fukuoka University Hospital publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 5 Lung Cancer Research Studies Oncology 2 works
- 6 Mycobacterium research and diagnosis Epidemiology 2 works
- 7 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 2 works
- 8 Esophageal and GI Pathology Surgery 2 works
- 9 COVID-19 Clinical Research Studies Infectious Diseases 2 works
- 10 Colorectal Cancer Surgical Treatments Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fukuoka University Hospital's research output changed?
Output in 2018–2022 was 16% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Fukuoka
- Kyushu University
- Fukuoka University
- Fukuoka Institute of Technology
- Kyushu University Hospital
- Kyushu Sangyo University
- National Hospital Organization Kyushu Cancer Center
- Fukuoka Dental College
- National Kyushu Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.